Facile assembly of soft nanoarchitectures and co-loading of hydrophilic and hydrophobic molecules via flash nanoprecipitation
Described herein are flash nanoprecipitation methods capable of encapsulating hydrophobic molecules, hydrophilic molecules, bioactive protein therapeutics, or other target molecules in amphiphilic copolymer nanocarriers.
1. A polymersome comprising:
poly(ethylene glycol)-bl-poly(propylene sulfide) (PEG-bl-PPS); and
rapamycin;
wherein the polymersome comprises both an aqueous core and a lipophilic bilayer membrane.
2. The polymersome of claim 1 , wherein the PEG-bl-PPS has a glass transition temperature below 0° C.
3. The polymersome of claim 1 , wherein the PEG-bl-PPS is PEG 17 -bl-PPS 30 -Thiol.
4. The polymersome of claim 1 , wherein the polymersome is less than 1060 nm in diameter.
5. The polymersome of claim 4 , wherein the polymersome is less than 700 nm in diameter.
6. A composition comprising the polymersome of claim 1 and a pharmaceutically acceptable carrier.
7. A polymersome loaded with rapamycin produced by a flash precipitation method comprising the steps of:
(i) providing an organic phase solution comprising poly(ethylene glycol)-bl-poly(propylene sulfide) (PEG-bl-PPS) and a process solvent, wherein the PEG-bl-PPS has a glass transition temperature below 0° C.,
(ii) providing an aqueous phase solution comprising an aqueous solvent and the rapamycin,
(iii) mixing the organic phase solution and the aqueous phase solution by impingement to form a mixture, and
(iv) introducing the mixture into a reservoir to cause precipitation of the PEG-bl-PPS as the polymersome loaded with rapamycin,
wherein the rapamycin is provided in at least one of the process solvent and the aqueous solvent, and
wherein the polymersome comprises both an aqueous core and a lipophilic bilayer membrane.
8. The polymersome of claim 7 , wherein the organic phase and the aqueous phase are impinged once.
9. The polymersome of claim 7 , wherein PEG weight fraction of the PEG-bl-PPS is about 0.12.
10. The polymersome of claim 9 , wherein the PEG-bl-PPS is PEG 17 -bl-PPS 30 -Thiol.
11. The polymersome of claim 7 , wherein the polymersome is monodisperse.
12. The polymersome of claim 7 , wherein the process solvent is selected from the group consisting of tetrahydrofuran (THF), dimethylformamide (DMF), and dimethyl sulfoxide (DMSO).
13. The polymersome of claim 7 , wherein the aqueous solvent is water.
14. The polymersome of claim 13 , wherein the aqueous solvent further comprises salt.